Read the primary source rather than the write-up and the two do not agree, so here is what is actually in it.
The gallbladder signal is real and it is mostly the weight loss, not the drug. Rapid loss increases biliary cholesterol saturation and reduces gallbladder motility, which is the classic recipe for stones — the same effect appears after bariatric surgery and in very-low-calorie dieting, without any GLP-1 involved. Trial data shows a modest absolute increase in cholelithiasis, concentrated in faster losers.
Where I think it is weakest: the subgroup findings are the part I trust least — with enough subgroups something is always significant, and these were not all pre-registered.
The question I want answered is how much of the gallbladder signal is the drug and how much is simply the rate of weight loss, because the answer changes what you can do about it. Numbers rather than impressions, if you have them.
Figures above are from the primary publication rather than the press summary. If a number here disagrees with one you have, post yours and we will work out which of us is reading a secondary source.
PharmacoVig_BOS said:The gallbladder signal is real and it is mostly the weight loss, not the drug.
All true, with one condition: that curve is for people who reached the dose on schedule. Anyone who slowed the ladder for tolerability is on a different, flatter curve, and comparing yourself with the published mean will make you feel like a non-responder when you are not.
PharmacoVig_BOS said:The gallbladder signal is real and it is mostly the weight loss, not the drug.
This is where I part company with the consensus forming above. The trial means are being read too generously in this thread. STEP populations were selected, supported, and titrated by protocol, and the real-world curves are consistently a few points worse. That difference is not noise, it is what happens when you remove the study infrastructure.
Ask again with the specifics and you will get a better answer than this one.
PeptideDetective — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsShort answer first, then the reasoning. Steady state is the thing most people miss. The terminal half-life is about a week, so every dose step takes four to five weeks to fully express itself. Judging a step at day ten is judging the ascent, not the plateau, and it is the single commonest reason people escalate before they needed to.
Dr.ReproEndo said:All true, with one condition: that curve is for people who reached the dose on schedule.
That holds for the injectable. The oral formulation has different absorption behaviour and the dose numbers are not interchangeable, which is worth saying out loud because people quote them as if they were.
Correct me if the detail matters more than I have assumed.